Chongqing General Hospital
13
3
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
Role: collaborator
Real-Time Algorithm-Driven Ventilation Feedback to Improve Lung-Protective Ventilation in Critically Ill Patients
Role: collaborator
Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
Role: collaborator
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Role: collaborator
Artificial Intelligence-assisted Diagnosis
Role: collaborator
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
Role: collaborator
Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage
Role: collaborator
Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
Role: lead
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
Role: lead
Whey Protein and Carbohydrates in ERAS for Recovery After Thyroidectomy: A Cohort Study
Role: lead
HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon Cancer
Role: collaborator
Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting
Role: collaborator
Narrow Band Imaging Versus White Light for the Detection and Miss of Sessile Serrated Lesion
Role: collaborator
All 13 trials loaded